Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) was $53.32 for the day, up 4.49% from the previous closing price of $51.03. In other words, the price has increased by $4.49 from its previous closing price. On the day, 0.69 million shares were traded.
Ratios:
Our analysis of RYTM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.34 and its Current Ratio is at 3.49. In the meantime, Its Debt-to-Equity ratio is 22.73 whereas as Long-Term Debt/Eq ratio is at 22.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on January 02, 2025, initiated with a Buy rating and assigned the stock a target price of $80.
On December 20, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $76.
On October 21, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $70.Guggenheim initiated its Buy rating on October 21, 2024, with a $70 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 19 ’25 when Smith Hunter C sold 2,215 shares for $57.22 per share. The transaction valued at 126,742 led to the insider holds 109,929 shares of the business.
Shulman Joseph sold 1,228 shares of RYTM for $70,266 on Feb 19 ’25. The Chief Technical Officer now owns 8,509 shares after completing the transaction at $57.22 per share. On Feb 19 ’25, another insider, Meeker David P, who serves as the President and CEO of the company, sold 9,896 shares for $57.22 each. As a result, the insider received 566,249 and left with 201,281 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 29.12 while its Price-to-Book (P/B) ratio in mrq is 292.08.
Stock Price History:
Over the past 52 weeks, RYTM has reached a high of $68.58, while it has fallen to a 52-week low of $35.17. The 50-Day Moving Average of the stock is -6.29%, while the 200-Day Moving Average is calculated to be 5.50%.
Shares Statistics:
A total of 61.44M shares are outstanding, with a floating share count of 55.24M. Insiders hold about 10.11% of the company’s shares, while institutions hold 97.61% stake in the company.
